Document is current
Any future updates will be listed below
-
Authors
Kluesner, Mitchell G. http://orcid.org/0000-0001-5828-9204
Lahr, Walker S.
Lonetree, Cara-lin
Smeester, Branden A. http://orcid.org/0000-0001-9421-1711
Qiu, Xiaohong
Slipek, Nicholas J. http://orcid.org/0000-0003-2664-6507
Claudio Vázquez, Patricia N.
Pitzen, Samuel P. http://orcid.org/0000-0001-6556-0461
Pomeroy, Emily J. http://orcid.org/0000-0001-7690-3570
Vignes, Madison J.
Lee, Samantha C. http://orcid.org/0000-0002-2794-2706
Bingea, Samuel P.
Andrew, Aneesha A.
Webber, Beau R. http://orcid.org/0000-0002-3950-8747
Moriarity, Branden S.
-
Funding
Funding for this research was provided by:
Children’s Cancer Research Fund
- License Information
-
More Information
Article History
Received: 9 April 2020
Accepted: 24 February 2021
First Online: 23 April 2021
Competing interests
: The authors declare the following competing interests: B.R.W. and B.S.M. are consultants for Beam Therapeutics. B.R.W and B.S.M. have financial interests in Beam Therapeutics. M.G.K., W.S.L., C.L.L., E.J.P., B.R.W., and B.S.M. are inventors of a full patent <i>Lymphohematopoietic engineering using cas9 base editors</i> (WO2019178225A2), which covers the application of using base editing for gene disruption in lymphohematopoietic cells. All Author’s interests were reviewed and are managed by the University of Minnesota in accordance with their conflict of interest policies. The Authors B.A.S., X.Q., N.J.S., P.N.C., S.P.B., S.P.P., S.C.L., and A.A.A. declare no competing interests.
